Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells

TY - JOUR

T1 - Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells

AU - Muller, D

AU - Jones, P M

AU - Persaud, S J

PY - 2006/12/22

Y1 - 2006/12/22

N2 - Insulin and glucose inhibited apoptosis in the MIN6 insulin-secreting cell line. The protective effect of 25 mM glucose was prevented by an anti-insulin antibody and this antibodyinduced increase in apoptosis was reversed by the presence of excess insulin. Glucose stimulated MIN6 cell proliferation and this was inhibited by blockade of insulin secretion, by an anti-insulin antibody and by phosphatidylinositol-3 kinase (PI-3K) inhibition. Furthermore, MIN6 cell proliferation was stimulated by depolarising concentrations of KCI and by insulin itself. These data indicate that insulin secreted by beta-cells in response to elevated glucose exerts autocrine effects to protect against apoptosis and stimulate proliferation, and suggest that the insulin signalling cascade, through the PI-3K pathway, may be an effective means of maintaining beta-cell mass in diabetes. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved

AB - Insulin and glucose inhibited apoptosis in the MIN6 insulin-secreting cell line. The protective effect of 25 mM glucose was prevented by an anti-insulin antibody and this antibodyinduced increase in apoptosis was reversed by the presence of excess insulin. Glucose stimulated MIN6 cell proliferation and this was inhibited by blockade of insulin secretion, by an anti-insulin antibody and by phosphatidylinositol-3 kinase (PI-3K) inhibition. Furthermore, MIN6 cell proliferation was stimulated by depolarising concentrations of KCI and by insulin itself. These data indicate that insulin secreted by beta-cells in response to elevated glucose exerts autocrine effects to protect against apoptosis and stimulate proliferation, and suggest that the insulin signalling cascade, through the PI-3K pathway, may be an effective means of maintaining beta-cell mass in diabetes. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved

U2 - 10.1016/j.febslet.2006.11.066

DO - 10.1016/j.febslet.2006.11.066

M3 - Article

SN - 0014-5793

VL - 580

SP - 6977

EP - 6980

JO - FEBS Letters

JF - FEBS Letters

IS - 30

ER -